# ARCHITECTURE AUDIT — V2 (Independent, First-Principles)

**Prepared by:** the independent XERDNA Scientific Architecture Review Board — a body distinct from, and not bound by the prior conclusions of, the Founding Scientific Architecture Board that authored `DOCS/ARCHITECTURE_AUDIT.md` (V1) and the earlier draft of this document.
**Status:** Governance report, not implementation. This document supersedes the earlier `DOCS/ARCHITECTURE_AUDIT_V2.md` draft in place (same filename, overwritten) and treats every finding in `DOCS/ARCHITECTURE_AUDIT.md` (V1) as unverified until independently reconfirmed here — no prior finding's "closed" status is taken on faith. Nothing in this document modifies any other file. This is the Audit stage (MASTER_CONTEXT.md Article XII, stage 5) of a full, from-scratch pass, undertaken because this review is understood to determine whether the first implementation in XERDNA's history is permitted to begin.

**Method:** every constitutional and architectural document was re-read in full for this pass — README.md, VISION.md, MASTER_CONTEXT.md (current, v1.1, including Article XII), ROADMAP.md, GRAPH/SCHEMA.md (current, v1.1), GRAPH/SCHEMA_REVIEW.md, GRAPH/SCHEMA_DECISIONS.md, DOCS/ARCHITECTURE_AUDIT.md, DOCS/ARCHITECTURE_REMEDIATION_PLAN.md, DOCS/GOVERNANCE_PIPELINE_AMENDMENT_PROPOSAL.md, DOCS/CONSTITUTIONAL_RATIFICATION.md, DOCS/PHASE_001_APPROVAL.md. No claim below is inherited from a prior audit without independent verification against the current text. Where a scientific or ontological claim required verification, verification was performed by live lookup (WebSearch against the authoritative source), not inferred from memory — per the standing rule that scientific metadata is never invented.

---

## 1. Constitutional Integrity

VISION.md, MASTER_CONTEXT.md, and ROADMAP.md were each re-read for internal self-consistency (does each document contradict itself) and for consistency with each other.

- VISION.md: internally consistent. Its ten articles (Mission, Origin, What XERDNA Is Not, Evidence Principles, Scientific Principles, AI Principles, Ethical Principles, Scientific Integrity as Supreme Constraint, Permanent Architectural Rules, Tagline) do not conflict with one another on re-read. No finding.
- ROADMAP.md: internally consistent. Its phase sequencing (Articles II–IX) and its framing articles (I, X, XI) do not conflict. Article I's "phases overlap... Phase 1 never actually finishes" is explicitly reconciled against a possible reading as an infinite deferral, by the same article's "centers of gravity, not hard gates" language — re-verified, holds up under a skeptical read. No finding.
- MASTER_CONTEXT.md: internally consistent on all but one point, found new this pass — see **Finding C1**, below (Section 4, Authority Hierarchy).

**Verdict: sound, with one new finding (C1) carried into Section 4.**

## 2. Governance Integrity

Article XII (Phase Governance Pipeline) was re-read against Article III's amendment process to confirm it was actually, not just claimedly, ratified correctly.

- Amendment Log (Article XI) contains a version 1.1 row citing the change and a stated rationale — present, matches Article III Rule 3's requirement.
- Article I Level 5 was amended in the same edit, consistent with what the Amendment Log row claims.
- Article XII's own text explicitly disclaims altering Article I's precedence or ROADMAP's sequencing — re-verified true on inspection; Article I's six levels are unchanged in count and order, and ROADMAP.md was independently re-read and confirmed byte-for-byte unmodified.

**Verdict: the pipeline is genuinely, not just nominally, constitutional. No new finding.** (V1's Finding 4.2 and the prior draft's confirmation are both independently reconfirmed here, not merely inherited.)

## 3. Scientific Integrity

VISION.md Article IV (Evidence Principles) and Article VIII (Scientific Integrity as Supreme Constraint) were checked against every place SCHEMA.md operationalizes them.

- The three-tier separation is structurally enforced in SCHEMA.md (different required field sets per tier, not just a label) — re-verified by reading the Evidence Model, Confidence Model, Hypothesis Model, and Prediction Model sections in full.
- One gap found new this pass: **Finding S2** (Section 8, Evidence Model) — Checked-Absent Records, added under P1, are not reconciled against Article II Rule 1's blanket tiering requirement.
- A second gap found new this pass: **Finding S1** (Section 7, Ontology Consistency) — the scientific accuracy of the Biolink/OBO category names used throughout SCHEMA.md has not been fully verified against the now-pinned versions.

**Verdict: sound in structure, with two new findings (S1, S2) that bear directly on scientific accuracy and are treated as blocking, given this review's stakes.**

## 4. Authority Hierarchy

Article I was read in isolation, then checked against every other article and document that describes document relationships.

**Finding C1 — Article X's document order does not match Article I's precedence order, and neither article states these are different axes — New, Constitutional, `High`.**

- Article I's Authority Hierarchy: 1. VISION.md, 2. MASTER_CONTEXT.md, 3. ROADMAP.md, 4. README.md, 5. design/governance artifacts, 6. Implementation.
- Article X, "How the Constitutional Documents Fit Together," lists the same four constitutional documents in a *different* order: README.md, VISION.md, ROADMAP.md, MASTER_CONTEXT.md.
- Article X does not state it is describing a different axis (orientation/reading order) rather than precedence — a reader encountering Article X without first internalizing Article I's exact order could reasonably, if incorrectly, infer that Article X restates precedence and conclude README ranks above VISION, or that the four are listed in ascending authority.
- This is the same category of ambiguity Article XII was just amended into the constitution specifically to *avoid* for the pipeline's own consultation order (see DOCS/GOVERNANCE_PIPELINE_AMENDMENT_PROPOSAL.md Section 1, which treats "reading order vs. precedence order" conflation as a named risk worth an explicit disclaimer) — yet the same ambiguity has existed in the *original*, v1.0 ratified constitutional text since before this session began, and was not caught by V1's audit or the prior draft of this document.
- **Constitutional articles affected:** MASTER_CONTEXT.md Article I (unaffected in substance, but the source of truth this finding is measured against), Article X (the actual defect).
- **Why this rises to blocking severity for this review:** this Board's mandate is explicitly to determine readiness for the *first* implementation in XERDNA's history, evaluated as if no prior approval existed. An ambiguity sitting inside the ratified authority-hierarchy chapter itself is a foundational-layer defect, not a downstream one — and the project has just demonstrated, in ratifying Article XII, that it treats this exact class of ambiguity as worth a formal amendment rather than an informal read-around.
- **Not applied here.** Per this Board's operating rule (no implementation, no code, audit only), no edit is made. The smallest closing move would be one added sentence to Article X stating explicitly that its ordering is expository (why → what/when → operating law → orientation, or similar), not a restatement of Article I's precedence — but drafting that sentence is Remediation-stage work, not Audit-stage work.

**Verdict: Authority Hierarchy is otherwise sound and correctly reflected everywhere else it's cited (SCHEMA.md, SCHEMA_REVIEW.md, SCHEMA_DECISIONS.md, Article XII itself all correctly cite Article I's actual order, not Article X's). One new, isolated defect (C1).**

## 5. Traceability

Every "Constitutional basis" / "Serves:" citation in GRAPH/SCHEMA.md, GRAPH/SCHEMA_REVIEW.md, and GRAPH/SCHEMA_DECISIONS.md was spot-checked against the article it cites, not merely checked for presence.

- Spot-checks performed: SCHEMA.md's Evidence Model citing VISION.md Article IV — confirmed Article IV is in fact the Evidence Principles article. SCHEMA.md's new E2 rule citing VISION.md Article VIII — confirmed Article VIII is in fact Scientific Integrity as Supreme Constraint, a correct fit for a tier-blurring concern. SCHEMA.md's Hypothesis Model H1 rule citing ROADMAP.md Article IV — confirmed Article IV is in fact Phase 3, Hypothesis Engine. All spot-checks passed; no mismatched citation found.
- **Finding, Low, carried forward and reconfirmed:** SCHEMA.md's top-of-document "Constitutional basis" line has not been updated to cite Article XII, despite SCHEMA.md now being the concrete example Article XII's own text uses for its "Architecture" stage. Not a broken citation — an incomplete one. Listed under Section 17 (Editorial backlog).

**Verdict: sound. Citations checked are accurate, not merely present.**

## 6. Cross-Document Consistency

Numeric claims and restated facts were checked pairwise across documents.

- GRAPH/SCHEMA_DECISIONS.md's Decision Summary table (15 ACCEPT NOW / 8 DEFER / 2 REJECT) was recounted independently against its own 25 individually-classified findings — recount matches exactly (D1–D6 = 6, E1–E4 = 4, H1–H4 = 4, O1–O4 = 4, P1–P3 = 3, R1–R4 = 4; total 25; ACCEPT NOW: E1,E2,E3,E4,H1,H2,H4,O1,O2,O3,O4,P1,R1,R2,R4 = 15; DEFER: D1,D2,D3,D4,D5,H3,P2,P3 = 8; REJECT: D6,R3 = 2). Confirmed correct.
- README.md's Status paragraph and MASTER_CONTEXT.md Article VIII's Repository status line were compared word-for-word — identical in substance, consistent phrasing. Confirmed.
- GRAPH/SCHEMA.md's Schema Changelog v1.1 row was checked against the actual 15 IDs present in the document body — all 15 present, none missing, none extra. Confirmed (reconfirms the prior draft's Question 4 finding, independently).
- **New finding — DOCS/PHASE_001_APPROVAL.md is stale and internally contradicted by DOCS/CONSTITUTIONAL_RATIFICATION.md and GRAPH/SCHEMA.md's own changelog.** DOCS/PHASE_001_APPROVAL.md still states "14 ACCEPT NOW" (actual: 15), still lists all three Blockers as unresolved (actual: all three resolved, per DOCS/CONSTITUTIONAL_RATIFICATION.md and GRAPH/SCHEMA.md's Schema Changelog v1.1 row), and its final decision line, `NOT APPROVED`, rests on that outdated premise. This finding is independently reconfirmed in this from-scratch pass (it is not inherited from the prior draft) — the document was re-read in full for this audit and the staleness verified directly. This is the reason DOCS/PHASE_001_APPROVAL_V2.md is being produced as a successor rather than an edit to the existing file, per this Board's instructions.
- **New finding, Low — DOCS/ARCHITECTURE_AUDIT.md (V1)'s self-description is now inaccurate.** V1's opening Status section states it "deliberately does not self-assign a level in MASTER_CONTEXT.md Article I" because "Article I has no defined category for meta-documents." Article I Level 5 has since been amended to explicitly include audit documents. V1 itself has not been (and, being a historical record, arguably should not be) edited to reflect this — but a reader encountering V1 without also reading Article XII's ratification could be misled about the current authority level of audit documents. Listed under Section 17.

**Verdict: mostly sound; two staleness findings, one severe (the Approval document) and already addressed by this session's own instructions, one minor.**

## 7. Ontology Consistency

**Finding S1 — Biolink/OBO term-level validity has not been fully verified against the pinned versions — New, Scientific, `Medium` (downgraded from an initial `High` concern after spot-checking).**

- O1 (pinning Biolink Model v4.3.7 and seven OBO releases) was correctly applied — the version *numbers* are real, verified-at-the-time-of-pinning values (confirmed by this Board via independent WebSearch against biolink.github.io and the respective ontology sources, not merely trusted from the prior session's work).
- What O1 does *not* do, and what SCHEMA.md does not claim to have done: individually re-verify that all ~19 Biolink category names used in the Biological Entity Types table (`biolink:Genome`, `biolink:Gene`, `biolink:NucleicAcidEntity`, `biolink:Transcript`, `biolink:Protein`, `biolink:Cell`, `biolink:Pathway`, `biolink:OrganismTaxon`, `biolink:SequenceVariant`, `biolink:Drug`, `biolink:ChemicalEntity`, `biolink:ClinicalTrial`, `biolink:InformationContentEntity`, `biolink:PopulationOfIndividualOrganisms`, `biolink:Publication`, `biolink:InformationResource`, `biolink:Disease`, `biolink:PhenotypicFeature`, `biolink:AnatomicalEntity`) and the predicates named in the Relationship Types and new E2/O4 rules (`biolink:interacts_with`, `biolink:part_of`, `biolink:correlated_with`, `biolink:causes`, etc.) still exist, unchanged in meaning, under the specific pinned v4.3.7 release. SCHEMA_REVIEW.md's own O1 finding explicitly warned Biolink "has made backward-incompatible category changes across major versions" — this is not a hypothetical risk to check, it is a documented historical pattern for this exact dependency.
- **This Board performed spot-checks, not a full pass:** `biolink:Genome`, `biolink:SequenceVariant`, and `biolink:PopulationOfIndividualOrganisms` were independently verified via WebSearch to exist as real, current Biolink Model classes. All three passed. This is informative — it suggests the entity table is not obviously broken — but three of nineteen terms, plus zero of the cited predicates, is a spot-check, not a verification. Severity is set to `Medium` rather than `High` specifically because the spot-check found no errors, not because the underlying gap is small.
- **Constitutional relevance:** the newly-stated standing rule ("never invent scientific metadata... always verify from authoritative sources before updating constitutional or architectural documents") applies with full force here — SCHEMA.md's entity and predicate tables were written *before* that rule was stated as an explicit standing instruction, and have not been retroactively re-verified under it.
- **Recommendation (not applied here):** a full term-by-term verification pass against Biolink Model v4.3.7 specifically (not "Biolink" generally) is required before any implementation that depends on these specific category/predicate names — most acutely, before the first `DATA/` ingestion connector is authorized, since that is where these names first become load-bearing rather than descriptive.

**Verdict: the versioning mechanism (O1) is sound and honestly implemented; the term-validity question it enables checking has not itself been fully checked. Treated as blocking for this review, given the stakes stated for it.**

## 8. Evidence Model

**Finding S2 — Checked-Absent Records are not reconciled against Article II Rule 1 — New, Scientific, `Medium`, treated as blocking.**

- MASTER_CONTEXT.md Article II Rule 1 (a Non-Negotiable Rule): "Every biological claim XERDNA surfaces is exactly one of Established Evidence, Computational Prediction, or Research Hypothesis... If a piece of data cannot be tagged with one of these tiers and its provenance, it does not enter the system."
- GRAPH/SCHEMA.md's Checked-Absent Records section (added under P1) defines a `checked_absent` record with fields `subject`/`predicate`/`object`, `checked_by`, `checked_at`, `scope` — no `evidence_tier` field, and no statement of whether Article II Rule 1 applies to it.
- The most defensible reading is that a `checked_absent` record is not itself a "biological claim" (it asserts nothing about biology — it records that a search was performed and came up empty) and is therefore reasonably exempt from Rule 1's tiering requirement. But SCHEMA.md does not say this. As written, a strict reading of Article II Rule 1 ("every piece of data... does not enter the system" without a tier) is in unstated tension with a schema section that defines a new kind of record entering the graph with no tier field at all.
- A related, second gap: SCHEMA.md's Relationship Types section states "a relationship is never a bare edge — it is always an association, carrying every field defined in the Evidence, Provenance, Confidence, Hypothesis, and Prediction Models." A `checked_absent` record is subject/predicate/object-shaped, resembling a relationship, but is not described as an "association" and does not carry those fields either. SCHEMA.md does not state whether `checked_absent` is a third kind of graph object outside both the tiered-association system and the plain-node system, or whether it should be reconciled into one of them.
- **Why this is Scientific, not merely Architectural:** the entire purpose of Article II Rule 1 and the tier system is preventing exactly the kind of "untagged data enters the graph" ambiguity this section creates, even if the specific instance here is very likely benign in intent. The Anti-Hallucination Rules and Scientific Integrity Constraints sections of SCHEMA.md itself are built on the premise that every rule of this kind is stated explicitly, not left to a "probably fine" inference — this gap is inconsistent with that premise, applied to the document's own newest section.
- **Recommendation (not applied here):** SCHEMA.md's Checked-Absent Records section should state explicitly whether it is exempt from Article II Rule 1 and from the "every relationship is an association" rule, and why — a one-paragraph clarification, not a structural change.

**Verdict: the three-tier model itself (established_evidence / computational_prediction / research_hypothesis) remains structurally sound and unmodified. The newly-added Checked-Absent Records section is the one place this pass found an unreconciled edge against it.**

## 9. Provenance Model

Re-read in full: `primary_knowledge_source`, `aggregator_knowledge_source`, `retrieved_at`, `source_record_id`, and the new `status` field (E3). All five fields are individually well-defined, each with a stated purpose distinguishable from the others (no field is redundant with another). The `status` field's default (`active`) and its three-value range (`active` / `retracted` / `superseded_by:<id>`) were checked against E3's original finding in SCHEMA_REVIEW.md and SCHEMA_DECISIONS.md — matches the accepted design exactly. **No finding.**

## 10. Confidence Model

Re-read in full. The tier-dependent presence/absence of `confidence` (none for established_evidence, numeric-or-qualitative with an explicit `confidence_type` for computational_prediction, qualitative-only for research_hypothesis) was checked against VISION.md Article VIII for whether any of the three treatments could itself constitute tier-blurring — none do; each treatment is more conservative than a naive uniform confidence field would be, which is the correct direction of error for this model. **No finding.**

## 11. Hypothesis Model

Re-read in full, including the three ACCEPT NOW additions (H1 promotion boundary, H2 subgraph-scoped claims, H4 non-terminal status). Checked H1's rule text against ROADMAP.md Article IV's Phase 3 description for consistency — the rule correctly reserves promotion mechanics for Phase 3 while stating the *boundary* now, matching SCHEMA_DECISIONS.md's H1 entry exactly. Checked H4 against VISION.md Article III ("no 'done'") — correct application. **No finding.**

## 12. Prediction Model

Re-read in full, including O2's `method` controlled-vocabulary rule. The `ontology_gap: true` fallback mechanism was checked against Anti-Hallucination Rule 6 ("confidence is never invented to fill a required field") for whether it establishes a consistent pattern — it does; both mechanisms follow the same shape (state the gap explicitly rather than filling it with an invented value), reinforcing rather than conflicting with the existing rule. **No finding.**

## 13. Identity Model

Re-read in full, including O3 (chemical granularity check) and R2 (split/merge lineage). Checked R2's new predicates (`xerdna:split_into`, `xerdna:merged_from`) against the Namespace Registry section's governance clause — see **Finding A1**, below (Section 17), which questions whether the registry's stated field schema (built around entity-type prefixes) actually covers predicate minting the way it has, in practice, already been used for. The identity resolution policy itself (canonical ID, xrefs, `xerdna:possibly_same_as` for unresolved ambiguity) is unchanged and was re-confirmed sound.

## 14. Versioning Model

Re-read in full. `schema_version` (R1) and the Schema Changelog are correctly distinguished from the constitutional Amendment Log (Article XI) — different purpose, different document, explicitly stated as such in both places. Cross-checked: **Finding, Low, carried forward and reconfirmed** — the Schema Changelog's v1.0 entry, and the Pinned Vocabulary Versions table's column header, both use the word "ratified" / "at ratification" to describe SCHEMA.md's own state — a term Article III reserves specifically for VISION/MASTER_CONTEXT/ROADMAP amendments. This appears in **two** places in the current text, not one (the earlier draft of this audit caught only the changelog instance). Listed under Section 17.

## 15. Circular Dependency Detection

Full citation graph re-traced from scratch, not assumed from the prior draft:

- MASTER_CONTEXT.md Article XII → Article I, Article II Rule 5, VISION.md Article IX, MASTER_CONTEXT.md Article IV, ROADMAP.md Article I — five one-directional citations, none reciprocated. No cycle.
- GRAPH/SCHEMA.md → VISION.md (Articles IV, V, VI, VIII, IX), MASTER_CONTEXT.md (Articles I, II, IV, V, VI, XII implicitly via Level 5), ROADMAP.md (Article II, III, IV, V, VI), GRAPH/SCHEMA_DECISIONS.md (15 ID citations) — all one-directional; none of VISION/MASTER_CONTEXT/ROADMAP cite back to SCHEMA.md. No cycle.
- GRAPH/SCHEMA_DECISIONS.md → GRAPH/SCHEMA_REVIEW.md, GRAPH/SCHEMA.md, VISION.md, MASTER_CONTEXT.md, ROADMAP.md — one-directional. GRAPH/SCHEMA.md's citations of GRAPH/SCHEMA_DECISIONS.md (added this session) do not create a cycle with this, because SCHEMA.md's citations are provenance pointers ("this rule's content came from decision X"), not assertions that SCHEMA_DECISIONS.md's validity depends on SCHEMA.md — the dependency, such as it is, runs only SCHEMA_DECISIONS.md → SCHEMA.md ("these decisions become real once applied to SCHEMA.md"), which already existed and is not new.
- DOCS/GOVERNANCE_PIPELINE_AMENDMENT_PROPOSAL.md → MASTER_CONTEXT.md Article I, III, IV, V; VISION.md Article IX; ROADMAP.md Article I — one-directional, and the proposal itself performed and documented this exact check (its own Section 5); independently re-traced here and confirmed accurate.
- DOCS/CONSTITUTIONAL_RATIFICATION.md → MASTER_CONTEXT.md (recording what changed), VISION.md, ROADMAP.md (recording what did *not* change) — a historical record citing forward in time from its own ratification event; no document cites back to it in a way that would make its own validity circular.

**Verdict: no circular dependency found anywhere in the current citation graph. Confirmed independently, not inherited.**

## 16. Anti-Hallucination Compliance

Each of GRAPH/SCHEMA.md's eight Anti-Hallucination Rules was checked both for internal consistency and for whether this session's own conduct has complied with them, since this audit itself is subject to the newly-stated scientific-verification standing rule.

- Rule 3 ("`established_evidence` is never assigned by generative inference") and Rule 4 ("citations must resolve, not merely look plausible") were checked against this session's own practice in applying O1 — the pinned ontology versions were independently re-verified by this Board via live WebSearch (not merely trusted from the prior session), and found accurate. Compliant.
- Rule 6 ("confidence is never invented to fill a required field") checked against O2's `ontology_gap: true` mechanism — consistent pattern, as noted in Section 12. Compliant.
- The one gap found — the Biolink/OBO term-validity question (Finding S1) — is itself best understood as a compliance question under Rule 4's spirit ("a syntactically valid but unverified identifier is treated as absent, not as weak evidence"): the entity-type table's Biolink category names are syntactically valid and highly likely correct (per spot-checks), but not yet *fully* verified, and SCHEMA.md does not currently flag this the way it flags ChEBI's and SO's unpinned status. This is the same discipline the document already applies to two ontologies; it has not yet been applied to the entity/predicate names those ontologies define.

**Verdict: the eight rules are internally sound and, where checked, this session's own conduct complies with them. One finding (S1) identifies where the document's own stated discipline (flag what's unverified) has not yet been applied to itself as thoroughly as it could be.**

## 17. Long-Term Maintainability & 2,000-Phase Compatibility

- The 8 DEFER items (D1–D5, H3, P2, P3) remain open by design, each with a stated dependency and re-visit trigger — re-confirmed intact and unmodified. This is correct behavior, not a finding.
- The 2 REJECT items (D6, R3) remain closed with stated reopening conditions — re-confirmed intact.
- **Finding A1 — Namespace Registry's governance scope is ambiguous between entity-type prefixes and relationship predicates — New, Architectural, `Medium`, treated as blocking.** GRAPH/SCHEMA.md mints five `xerdna:` predicates in total across the document (`xerdna:claims`, `xerdna:cites` in Relationship Types; `xerdna:possibly_same_as` in Entity Identity; `xerdna:split_into`, `xerdna:merged_from`, newly added under R2, also in Entity Identity) — but the Namespace Registry section's field schema (`prefix`, `parent_type`, `introduced_in`, `rationale`, `status`) and its only given examples (`gene`, `protein`, `Patent`, `MicrobialCommunity`) are all entity-type prefixes. Nothing in the document states whether the same registry, with the same required `rationale` field, governs predicate minting too, or whether predicates need a parallel mechanism not yet defined. Given R2 just added two more predicates without addressing this, the gap is actively growing, not static — exactly the kind of "namespace sprawl by omission" the registry exists to prevent (per its own stated purpose), now potentially exempting the fastest-growing category of new `xerdna:` terms from its own discipline.
- **Low, carried forward and reconfirmed:** single point of failure in amendment authority (V1 Finding 5.2) — unchanged, still open, still long-horizon and non-urgent.
- **Low, carried forward and reconfirmed:** GRAPH/SCHEMA_DECISIONS.md R2 partly cites SCHEMA.md's own text as "constitutional justification" (V1 Finding 2.1) — unchanged, still open.
- **Low, carried forward and reconfirmed:** SCHEMA.md's Disease/Phenotype/Anatomy addition extends ROADMAP's Level-3 entity list via a Level-2 principle, without a ROADMAP-side acknowledgment (V1 Finding 4.3) — unchanged, still open.
- **Low, carried forward and reconfirmed:** SCHEMA.md's Extensibility Rule is stated near-verbatim in three separate places (V1 Finding 3.1) — unchanged, still open.
- **Low, carried forward and reconfirmed:** `xerdna:possibly_same_as` (entities) and the DEFER'd, not-yet-designed `xerdna:possibly_duplicate_of` (hypotheses, H3) are the same conceptual pattern under two different names, with no registry entry yet unifying them (V1 Finding 3.2) — unchanged, still open, and now sharpened by Finding A1 above (the pattern itself may not even be registry-governed, depending on how A1 is resolved).

---

## Consolidated Findings

| ID | Finding | Category | Severity | Status |
|---|---|---|---|---|
| C1 | Article X's document order doesn't match Article I's precedence order; no stated distinction | Constitutional | **High** | New |
| S1 | Biolink/OBO entity & predicate names not fully re-verified against pinned versions (spot-checks passed) | Scientific | **Medium** | New |
| S2 | Checked-Absent Records not reconciled against Article II Rule 1 or the "every relationship is an association" rule | Scientific | **Medium** | New |
| A1 | Namespace Registry's governance scope unclear for predicates vs. entity-type prefixes; 5 predicates already minted | Architectural | **Medium** | New |
| — | DOCS/PHASE_001_APPROVAL.md stale (14 ACCEPT NOW; blockers listed as open; all now resolved) | Governance | High-class, self-resolving | Reconfirmed; resolved by this session producing V2 |
| — | DOCS/ARCHITECTURE_AUDIT.md (V1) self-description now outdated re: its own hierarchy level | Governance | Low | Reconfirmed |
| — | SCHEMA.md uses "ratified"/"at ratification" for Level-5 activity, in two places | Editorial | Low | Reconfirmed (scope widened: 2 instances, not 1) |
| — | SCHEMA.md's "Constitutional basis" line doesn't cite Article XII | Editorial | Low | Reconfirmed |
| — | SCHEMA_DECISIONS.md R2 self-cites SCHEMA.md as "constitutional justification" | Architectural | Medium | Reconfirmed, still open (V1 Finding 2.1) |
| — | SCHEMA.md's Disease/Phenotype/Anatomy addition extends ROADMAP via Article IV | Architectural | Medium | Reconfirmed, still open (V1 Finding 4.3) |
| — | Extensibility Rule restated three times in SCHEMA.md | Editorial | Low | Reconfirmed, still open (V1 Finding 3.1) |
| — | `possibly_same_as` / `possibly_duplicate_of` naming drift | Architectural | Low | Reconfirmed, still open (V1 Finding 3.2) |
| — | Single point of failure in amendment authority | Governance | Low | Reconfirmed, still open (V1 Finding 5.2) |

**Findings independently reconfirmed as closed this pass** (V1's 1.1, 1.2, 4.1, 4.2, 5.1, 5.3): all six re-verified directly against current document text in this from-scratch read, not inherited from the prior audit draft's say-so. All six remain closed.

**Net new to this independent pass: 4 findings (C1, S1, S2, A1) that neither V1 nor the earlier draft of this document surfaced.** Three of the four are treated as blocking for this review, given its stated stakes (C1, S1, S2); A1 is treated as blocking on the grounds that ungoverned predicate-minting is precisely the failure mode the Namespace Registry exists to prevent, and it is currently unaddressed while actively recurring.

---

## What This Report Recommends, Not Decides

This Board does not issue an approval decision here — that is DOCS/PHASE_001_APPROVAL_V2.md's function (Article XII, stage 7), produced as a companion to this audit. No document has been edited by this report. Four findings (C1, S1, S2, A1) are carried forward as blockers; the remainder are recorded as a non-blocking backlog, consistent with how this pipeline has treated Low/Medium findings throughout.
